Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 39 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Smilax glabra Roxb. Flavonoids Attenuate D-Galactose-Induced Cardiac Alterations and Are Associated with Modulation of the PGC-1α/NRF1/TFAM Axis and PINK1/Parkin Signaling Pathway in an AMPK-Associated Manner

  1. 1Department of Experimental Animals, Zhejiang Academy of Traditional Chinese Medicine, Hangzhou 310007, China

Abstract

Smilax glabra Roxb. flavonoids (SGF) are the rhizome extracts of Smilax glabra Roxb. and possesses pharmacological activity, prior studies have demonstrated SGF’s cardioprotective potential, specifically its capacity to inhibit pathological cardiac hypertrophy. Building upon this evidence, this study investigated whether SGF exerts protective effects against D-galactose-induced cardiac alterations and elucidated its underlying molecular mechanisms. D-galactose was employed to induce aging-like changes in C57BL/6J mice and H9c2 cell. The cardioprotective effects of SGF against D-galactose-induced myocardial alterations were investigated, with particular emphasis on mitochondrial ultrastructural integrity, expression of key factors in the PGC-1α/NRF1/TFAM axis and PINK1/Parkin signaling pathways, in relation to AMPK signaling. Additionally, in vitro, the AMPK inhibitor Compound C and the AMPK agonist AICAR were used to examine whether the cardioprotective effect of SGF was associated with AMPK. In vivo, SGF administration significantly attenuated D-galactose-induced cardiac hypertrophy, ameliorated myocardial fibrosis and ROS overproduction, preserved mitochondrial ultrastructure, enhanced AMPK phosphorylation (increased p-AMPKα/AMPK ratio), and upregulated the expression of key proteins involved in the PGC-1α/NRF1/TFAM axis and PINK1/Parkin signaling pathways. In vitro, SGF effectively suppressed D-galactose-induced senescence-like changes in H9c2 cells, these beneficial effects were abolished upon co-treatment with Compound C, and the action of SGF was similar to that of AICAR. These results suggested that SGF attenuated D-galactose-induced cardiac hypertrophy and preserves mitochondrial structure. These effects were accompanied by increased AMPK phosphorylation and increased expression of proteins related to PGC-1α/NRF1/TFAM axis and PINK1/Parkin signaling pathway. These changes were consistent with an AMPK-associated pattern and may contribute to the cardioprotective effects of SGF via effects on mitochondrial function.

Related

  1. Diosgenin Alleviates Neuropathic Pain Associated with Alterations in Spinal Mitochondrial and ER Stress-Related Factors in CCI Mice
    Md. Mahbubur Rahman, Taesu Yoon, Seung Hoon Yum +3
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  2. Proteomic and β-hydroxybutyrylation Landscapes Reveal AMPKα2-Associated Modulation in HUCMSC-Derived Exosome-Mediated Amelioration of Cardiac Aging
    Xuehui Li, Wenjing Ding, Xuechun Yang +8
    Molecular & Cellular ProteomicsPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
  3. Human Cardiac Organoids Reveal HAND1 Loss-Associated Alterations in Cell Composition During Early Cardiac Differentiation
    Hao Yang, Yunqian Zeng, Yiyang Teng +5
    CellsPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  4. Long-Term Effects of Isoflurane Anesthesia and Surgery: Sex-Associated Neurological Dysfunction and Alterations in Circulating Extracellular Vesicles
    Yun Li, Ruth Park, Balaji Krishnamachary +4
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  5. Hippocampal Glial Alterations Are Associated with Mitochondrial Changes and Reduced Glucocorticoid Receptor Density in Suicides
    Andrea Judith Vázquez-Hernández, Yali Escribano-Cadena, Julio César Morales-Medina +7
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
BibTeX
@article{fu2026smilax,
  title = {{Smilax glabra Roxb. Flavonoids Attenuate D-Galactose-Induced Cardiac Alterations and Are Associated with Modulation of the PGC-1α/NRF1/TFAM Axis and PINK1/Parkin Signaling Pathway in an AMPK-Associated Manner}},
  author = {Danting Fu and Jiajun Shi and Qinqin Yang and Chunwei Zheng and Yu Chen},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = nov,
  doi = {10.3390/ijms27219969},
  url = {https://www.mdpi.com/1422-0067/27/21/9969},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Smilax glabra Roxb. Flavonoids Attenuate D-Galactose-Induced Cardiac Alterations and Are Associated with Modulation of the PGC-1α/NRF1/TFAM Axis and PINK1/Parkin Signaling Pathway in an AMPK-Associated Manner
AU  - Danting Fu
AU  - Jiajun Shi
AU  - Qinqin Yang
AU  - Chunwei Zheng
AU  - Yu Chen
PY  - 2026
DA  - 2026/11/06
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27219969
UR  - https://www.mdpi.com/1422-0067/27/21/9969
AB  - Smilax glabra Roxb. flavonoids (SGF) are the rhizome extracts of Smilax glabra Roxb. and possesses pharmacological activity, prior studies have demonstrated SGF’s cardioprotective potential, specifically its capacity to inhibit pathological cardiac hypertrophy. Building upon this evidence, this study investigated whether SGF exerts protective effects against D-galactose-induced cardiac alterations and elucidated its underlying molecular mechanisms. D-galactose was employed to induce aging-like changes in C57BL/6J mice and H9c2 cell. The cardioprotective effects of SGF against D-galactose-induced myocardial alterations were investigated, with particular emphasis on mitochondrial ultrastructural integrity, expression of key factors in the PGC-1α/NRF1/TFAM axis and PINK1/Parkin signaling pathways, in relation to AMPK signaling. Additionally, in vitro, the AMPK inhibitor Compound C and the AMPK agonist AICAR were used to examine whether the cardioprotective effect of SGF was associated with AMPK. In vivo, SGF administration significantly attenuated D-galactose-induced cardiac hypertrophy, ameliorated myocardial fibrosis and ROS overproduction, preserved mitochondrial ultrastructure, enhanced AMPK phosphorylation (increased p-AMPKα/AMPK ratio), and upregulated the expression of key proteins involved in the PGC-1α/NRF1/TFAM axis and PINK1/Parkin signaling pathways. In vitro, SGF effectively suppressed D-galactose-induced senescence-like changes in H9c2 cells, these beneficial effects were abolished upon co-treatment with Compound C, and the action of SGF was similar to that of AICAR. These results suggested that SGF attenuated D-galactose-induced cardiac hypertrophy and preserves mitochondrial structure. These effects were accompanied by increased AMPK phosphorylation and increased expression of proteins related to PGC-1α/NRF1/TFAM axis and PINK1/Parkin signaling pathway. These changes were consistent with an AMPK-associated pattern and may contribute to the cardioprotective effects of SGF via effects on mitochondrial function.
SN  - 1422-0067
ER  -